[Beta-blockaders in the treatment of arterial hypertension. Part I. Pharmacologic, hemodynamic and metabolic aspects]
- PMID: 25158
[Beta-blockaders in the treatment of arterial hypertension. Part I. Pharmacologic, hemodynamic and metabolic aspects]
Similar articles
-
[Adrenergic beta receptor blockaders in the treatment of arterial hypertension].Pol Tyg Lek. 1982 Nov 15;37(44):1331-4. Pol Tyg Lek. 1982. PMID: 6131408 Polish. No abstract available.
-
Beta-blockers and the kidney: implications for renal function and renin release.Physiologist. 1985 Feb;28(1):53-63. Physiologist. 1985. PMID: 2858895 No abstract available.
-
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.Br J Clin Pharmacol. 1982 Jan;13(1):51-60. doi: 10.1111/j.1365-2125.1982.tb01336.x. Br J Clin Pharmacol. 1982. PMID: 6121573 Free PMC article. No abstract available.
-
beta Adrenergic blocking drugs.Pharmacol Ther. 1980;11(1):109-39. doi: 10.1016/0163-7258(80)90069-8. Pharmacol Ther. 1980. PMID: 6107938 Review. No abstract available.
-
Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.J Cardiovasc Pharmacol. 1983;5 Suppl 1:S30-45. doi: 10.1097/00005344-198300051-00006. J Cardiovasc Pharmacol. 1983. PMID: 6188918 Review. No abstract available.
Cited by
-
Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients.Br Med J. 1980 Jun 7;280(6228):1344-6. doi: 10.1136/bmj.280.6228.1344. Br Med J. 1980. PMID: 7388535 Free PMC article.